The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device

BACKGROUND: Rapid and accurate diagnosis of individuals with SARS-CoV-2 infection is an effective way to prevent and control the spread of COVID-19. Although the detection of SARS‐CoV‐2 viral RNA by RT‐qPCR is the gold standard for COVID-19 testing, the use of antigen-detecting rapid diagnostic test...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Kengo, Kitazawa, Hiroaki, Kawahata, Takashi, Yuhara, Kosuke, Masuya, Takahiro, Kuroita, Toshihiro, Waki, Kentarou, Koike, Seiichi, Isobe, Masaharu, Kurosawa, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523765/
https://www.ncbi.nlm.nih.gov/pubmed/37752417
http://dx.doi.org/10.1186/s12865-023-00567-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523765/
https://www.ncbi.nlm.nih.gov/pubmed/37752417
http://dx.doi.org/10.1186/s12865-023-00567-y

Ejemplares similares